๐ฌ Current Disease Focus:
Task Progress: 0%
๐ฅ Active Problem Solvers
0
๐ Experts collaborating globally
โก Current Task Assignment
๐งฌ Genetic Analysis
๐ Matching experts to specific tasks
๐ Resource Allocation by Research Phase:
๐ Data Analysis
๐งช Experimental Design
๐ฌ Clinical Trials
๐ Treatment Development
The primary purpose of this research study is to see whether adding bavitux...
Status
Completed
Location
Ironwood Cancer and Research Center
Start Date
2010-06
Trial ID
NCT01138163
Treatments Being Tested
This is a Phase Ib/IIa Study of Cabazitaxel plus Bavituximab in patients wi...
Status
Terminated
Location
Medical University of South Carolina
Start Date
2011-06
Trial ID
NCT01335204
Treatments Being Tested
This research study is studying a combination of drugs with radiation as a ...
Status
Completed
Location
Dana Farber Cancer Institute
Start Date
2017-09-13
Trial ID
NCT03139916
Treatments Being Tested
This will be a randomized, open-label, active-control Phase II pilot trial ...
Status
Completed
Location
LTD Vakhtang Bochorishvili Anticeptic Centre
Start Date
2011-01
Trial ID
NCT01273948
Treatments Being Tested
This study involves a course of radiation to up to 5 tumors in the particip...
Status
Withdrawn
Location
H. Lee Moffitt Cancer Center and Research Institute
Start Date
2017-03-27
Trial ID
NCT02989870
Treatments Being Tested
The primary objective of this study is to compare the overall survival of p...
Status
Completed
Location
Ironwood Cancer & Research Centers
Start Date
2011-01
Trial ID
NCT01272791
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy, such as paclitaxel, work in differen...
Status
Completed
Location
Arizona Cancer Center
Start Date
2011-01
Trial ID
NCT01288261
Treatments Being Tested
The purpose of this study is to determine the safety of bavituximab when ad...
Status
Completed
Location
Arizona Cancer Center
Start Date
2005-06
Trial ID
NCT00129337
Treatments Being Tested
The primary objective of this study is to determine the overall response ra...
Status
Completed
Location
Apollo Hospital
Start Date
2008-06
Trial ID
NCT00687817
Treatments Being Tested
This study evaluates the combination of bavituximab and pembrolizumab in th...
Status
Completed
Location
Smilow Cancer Hospital at Yale-New Haven
Start Date
2019-09-11
Trial ID
NCT04099641
Treatments Being Tested